Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × bomedemstat × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Thrombocythemia, Essential 2 Polycythemia Vera 2 Primary Myelofibrosis 1 Leukemia, Myeloid, Acute 1

Interventions

venetoclax 87 Azacitidine 69 Cytarabine 52 fludarabine 43 Specimen Handling 36 Biopsy 26 Daunorubicin 25 Cyclophosphamide 25 Decitabine 24 fludarabine phosphate 22 Injections 19 Granulocyte Colony-Stimulating Factor 18 Busulfan 17 Whole-Body Irradiation 16 Stem Cell Transplantation 15 Idarubicin 15 Mycophenolic Acid 14 Melphalan 14 Tacrolimus 13 CPX-351 13 gilteritinib 11 decitabine and cedazuridine drug combination 11 Filgrastim 11 enasidenib 9 ivosidenib 8 Mitoxantrone 8 Methotrexate 8 Magnetic Resonance Spectroscopy 8 Gemtuzumab 8 Cladribine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05597306 2026-01-08

VenBom

University of Miami

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡